Neutrophil serine proteases: Future therapeutic targets in patients with severe chronic neutropenia and leukemia?

Stem Cells

Volumn 24, Issue 9, 2006, Pages 2158-2159

  Garwicz, Daniel ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

SERINE PROTEINASE;

CD34 SELECTION; CELL DEATH; CELL PROLIFERATION; FOLLOW UP; GENE MUTATION; HUMAN; IN VITRO STUDY; LETTER; LEUKEMIA; NEUTROPENIA; NEUTROPHIL;

GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LEUKEMIA; NEUTROPENIA; NEUTROPHILS; SERINE ENDOPEPTIDASES;

EID: 33749159548     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2005-0584     Document Type: Letter

References (15)

1. + progenitor cells in the absence of serum is suppressed by the production of serine proteinases by their progeny. STEM CELLS 2006;24:299-306.
2. Garwicz D, Lennartsson A, Jacobsen SEW et al. Biosynthetic profiles of neutrophil serine proteases in a human bone marrow-derived cellular myeloid differentiation model. Haematologica 2005;90:38-44.
3. Sköld S, Rosberg B, Gullberg U et al. A secreted proform of neutrophil proteinase 3 regulates the proliferation of granulopoietic progenitor cells. Blood 1999;93:849-856.
4. Sköld S, Rosberg B, Olofsson T. The N-terminal tetrapeptide of neutrophil proteinase 3 causes S-phase arrest in granulopoietic progenitors. Exp Hematol 2005;33:1329-1336.
5. El Ouriaghli F, Fujiwara H, Melenhorst JJ et al. Neutrophil elastase enzymatically antagonizes the in vitro action of G-CSF: Implications for the regulation of granulopoiesis. Blood 2005;101:1752-1758.
6. Horwitz M, Benson KF, Person RE et al. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic hematopoiesis. Nature Genetics 1999;23:433-436.
7. Dale DC, Person RE, Bolyard AA et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 2000;96:2317-2322.
8. Massullo P, Druhan LJ, Bunnell BA et al. Aberrant subcellular targeting of the G185R neutrophil elastase mutant associated with severe congenital neutropenia induces premature apoptosis of differentiating promyelocytes. Blood 2005;105:3397-3404.
9. Carlsson G, Aprikyan AA, Tehranchi R et al. Kostmann syndrome: Severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells. Blood 2004;103:3355-3361.
10. Dale DC, Cottle TE, Fier CJ et al. Severe chronic neutropenia: Treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol 2003;72:82-93.
11. Donadieu J, LeBlanc T, Bader-Meunier B et al. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica 2005;90:45-53.
12. + cells identifies low expression of CD7 with high expression of proteinase 3 or elastase as predictors of longer survival in CML patients. Blood 2006;107:205-212.
13. Molldrem J, Dermine S, Parker K et al. Targeted T-cell therapy for human leukemia: Cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells. Blood 1996;88:2450-2457.
14. Molldrem JJ, Komanduri K, Wieder E. Overexpressed differentiation antigens as targets of graft-versus-leukemia reactions. Curr Opin Hematol 2002;9:503-508.
15. Fujiwara H, Melenhorst JJ, El Ouriaghli F et al. In vitro induction of myeloid leukemia-specific CD4 and CD8 T cells by CD40 ligand-activated B cells gene modified to express primary granule proteins. Clin Cancer Res 2005;11:4495-4503.